Literature DB >> 22359002

Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.

S Q Liu1, L S Liu, T Ohno.   

Abstract

Human tumor-specific CD4(+) cytotoxic T lymphocytes (CTL) were generated against duodenum papilloma cell line TGBC18TKB from HLA type-matched peripheral blood mononuclear cells. Concanavalin A (Con A) immobilized on carrier beads stimulated growth of the CTL in a long-term culture without repeated antigen stimulation, while soluble Con A induced death of the CTL. The CTL exhibited the target-specific cytotoxicity in a more potent manner than those before the long-term culture in the presence of the immobilized Con A. Enhanced expression of the adhesion molecule, CD11b, was observed on the CTL. These results suggest that immobilized Con A will be useful for continuous growth stimulation and large scale expansion of CTL without tumor antigen.

Entities:  

Year:  1998        PMID: 22359002      PMCID: PMC3449517          DOI: 10.1023/A:1007924430570

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  34 in total

Review 1.  Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets.

Authors:  D A Norris
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

2.  Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report.

Authors:  T Takayama; M Makuuchi; T Sekine; S Terui; H Shiraiwa; T Kosuge; S Yamazaki; H Hasegawa; K Suzuki; M Yamagata
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

3.  Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation.

Authors:  C van Noesel; F Miedema; M Brouwer; M A de Rie; L A Aarden; R A van Lier
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

4.  MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.

Authors:  N J Crowley; T L Darrow; M A Quinn-Allen; H F Seigler
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

5.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; K Sakaguchi; E Appella; J R Yannelli; G J Adema; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

6.  Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay.

Authors:  K Kawai; T Sasaki; K Saijo-Kurita; H Akaza; K Koiso; T Ohno
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

7.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.

Authors:  A Mazumder; E A Grimm; H Z Zhang; S A Rosenberg
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

8.  Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.

Authors:  T Wölfel; W Herr; P Coulie; U Schmitt; K H Meyer zum Büschenfelde; A Knuth
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

9.  Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigen.

Authors:  N Shinohara; J A Bluestone; D H Sachs
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.

Authors:  B Mukherji; A Guha; N G Chakraborty; M Sivanandham; A L Nashed; J R Sporn; M T Ergin
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.